{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:27:05Z","timestamp":1781522825224,"version":"3.54.1"},"reference-count":230,"publisher":"Harborside Press, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Testicular cancer (TC) is the most common cancer among men aged 18 to 39 years. It is highly curable, with a 10-year relative survival approaching 95% due to effective cisplatin-based chemotherapy. Given the increasing incidence of TC and improved survival, TC survivors (TCS) now account for approximately 4% of all US male cancer survivors. They have also become a valuable cohort for adult-onset cancer survivorship research, given their prolonged survival. Commensurately, long-term treatment-related complications have emerged as important survivorship issues. These late effects include life-threatening conditions, such as second malignant neoplasms and cardiovascular disease. Moreover, TCS can also experience hearing loss, tinnitus, neurotoxicity, nephrotoxicity, pulmonary toxicity, hypogonadism, infertility, anxiety, depression, cognitive impairment, and chronic cancer-related fatigue. Characterization of the number and severity of long-term adverse health outcomes among TCS remains critical to develop risk-stratified, evidence-based follow-up guidelines and to inform the development of preventive measures and interventions. In addition, an improved understanding of the long-term effects of TC treatment on mortality due to noncancer causes and second malignant neoplasms remains paramount. Future research should focus on the continued development of large, well-characterized clinical cohorts of TCS for lifelong follow-up. These systematic, comprehensive approaches can provide the needed infrastructure for further investigation of long-term latency patterns of various medical and psychosocial morbidities and for more in-depth studies investigating associated etiopathogenetic pathways. Studies examining premature physiologic aging may also serve as new frontiers in TC survivorship research.<\/jats:p>","DOI":"10.6004\/jnccn.2019.7369","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T20:06:32Z","timestamp":1575576392000},"page":"1557-1568","source":"Crossref","is-referenced-by-count":72,"title":["Testicular Cancer Survivorship"],"prefix":"10.6004","volume":"17","author":[{"given":"Chunkit","family":"Fung","sequence":"first","affiliation":[{"name":"aUniversity of Rochester School of Medicine and Dentistry, Rochester, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Dinh","sequence":"additional","affiliation":[{"name":"bIndiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana;"},{"name":"cDepartment of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie D.","family":"Fossa","sequence":"additional","affiliation":[{"name":"dNorwegian Radium Hospital, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois B.","family":"Travis","sequence":"additional","affiliation":[{"name":"bIndiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"ref811","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/cncr.11950","article-title":"Fertility after testicular cancer treatments: results of a large multicenter study","volume":"100","author":"Huyghe","year":"2004","journal-title":"Cancer"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"e12390","DOI":"10.1097\/MD.0000000000012390","article-title":"Recent global trends in testicular cancer incidence and mortality","volume":"97","author":"Park","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref1981","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/cncr.11950","article-title":"Fertility after testicular cancer treatments: results of a large multicenter study","volume":"100","author":"Huyghe","year":"2004","journal-title":"Cancer"},{"key":"ref1571","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djp413","article-title":"Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors","volume":"101","author":"Bryd\u00f8y","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref1821","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","article-title":"Evaluation of long-term toxicity after chemotherapy for testicular cancer","volume":"14","author":"Bokemeyer","year":"1996","journal-title":"J Clin Oncol"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref1841","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/jnci\/dji339","article-title":"Paternity following treatment for testicular cancer","volume":"97","author":"Bryd\u00f8y","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref2081","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urology.2008.08.501","article-title":"Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer","volume":"73","author":"Pettus","year":"2009","journal-title":"Urology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref1181","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-87-3-293","article-title":"Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer","volume":"87","author":"Einhorn","year":"1977","journal-title":"Ann Intern Med"},{"key":"ref1411","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jamaoncol.2016.3651","article-title":"Second malignant neoplasms and cause of death in patients with germ cell cancer: a Danish nationwide cohort study","volume":"2","author":"Kier","year":"2016","journal-title":"JAMA Oncol"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-16-3224","article-title":"Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer","volume":"23","author":"Dolan","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","article-title":"Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up","volume":"30","author":"Haugnes","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref2171","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/pon.3804","article-title":"Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients","volume":"24","author":"Amidi","year":"2015","journal-title":"Psychooncology"},{"key":"ref1611","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1158\/1078-0432.CCR-16-2809","article-title":"Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity","volume":"23","author":"Wheeler","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/01926230490508821","article-title":"Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology","volume":"32","author":"Vickers","year":"2004","journal-title":"Toxicol Pathol"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0302-2838(03)00263-X","article-title":"Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer","volume":"44","author":"Nord","year":"2003","journal-title":"Eur Urol"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMra1407550","article-title":"Testicular cancer\u2014discoveries and updates","volume":"371","author":"Hanna","year":"2014","journal-title":"N Engl J Med"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","article-title":"Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)","volume":"23","author":"Jones","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"487.e13","DOI":"10.1016\/j.urolonc.2016.06.012","article-title":"Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors","volume":"34","author":"Hjelle","year":"2016","journal-title":"Urol Oncol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1200\/JCO.2016.70.3108","article-title":"Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy","volume":"35","author":"Fung","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpsychores.2008.01.002","article-title":"Chronic cancer-related fatigue in long-term survivors of testicular cancer","volume":"64","author":"Orre","year":"2008","journal-title":"J Psychosom Res"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1743-6109.2009.01298.x","article-title":"Sexual function in men treated for testicular cancer","volume":"6","author":"Eberhard","year":"2009","journal-title":"J Sex Med"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","article-title":"Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Loren","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2017.77.0735","article-title":"Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study","volume":"36","author":"Kerns","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/andr.12177","article-title":"Testosterone deficiency in testicular cancer survivors\u2014a systematic review and meta-analysis","volume":"4","author":"Bandak","year":"2016","journal-title":"Andrology"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","article-title":"Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis","volume":"3","author":"Mustian","year":"2017","journal-title":"JAMA Oncol"},{"key":"ref2291","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11136-005-5370-6","article-title":"Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors","volume":"15","author":"Oldenburg","year":"2006","journal-title":"Qual Life Res"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01213011-200506000-00005","article-title":"Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients","volume":"15","author":"Nuver","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12032-014-0043-3","article-title":"Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors","volume":"31","author":"Alacacioglu","year":"2014","journal-title":"Med Oncol"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-07-0684","article-title":"Risk factors for post-treatment hypogonadism in testicular cancer patients","volume":"158","author":"Eberhard","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1200\/JCO.2008.18.5181","article-title":"Pulmonary function in long-term survivors of testicular cancer","volume":"27","author":"Haugnes","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref1961","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/1097-0142(20010401)91:7<1297::AID-CNCR1132>3.0.CO;2-Z","article-title":"The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors","volume":"91","author":"Gerl","year":"2001","journal-title":"Cancer"},{"key":"ref1861","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1111\/j.1743-6109.2009.01299.x","article-title":"Hypogonadism, decreased sexual desire, and long-term depression in middle-aged men","volume":"6","author":"Hintikka","year":"2009","journal-title":"J Sex Med"},{"key":"ref2041","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/bjc.2012.471","article-title":"Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer","volume":"107","author":"Bryd\u00f8y","year":"2012","journal-title":"Br J Cancer"},{"key":"ref1941","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/02841860601166958","article-title":"Gonadal dysfunction and fertility problems in cancer survivors","volume":"46","author":"Bryd\u00f8y","year":"2007","journal-title":"Acta Oncol"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/cncr.24981","article-title":"Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer","volume":"116","author":"Glendenning","year":"2010","journal-title":"Cancer"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1479-5876-5-70","article-title":"Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study","volume":"5","author":"Oldenburg","year":"2007","journal-title":"J Transl Med"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"78253","DOI":"10.18632\/oncotarget.20872","article-title":"Salvage therapy for relapsed testicular cancer","volume":"8","author":"Adra","year":"2017","journal-title":"Oncotarget"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<860::AID-IJC32>3.0.CO;2-L","article-title":"Therapy-related malignancies following treatment of germ cell cancer","volume":"83","author":"Kollmannsberger","year":"1999","journal-title":"Int J Cancer"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.genhosppsych.2015.09.001","article-title":"Anxiety and depression in long-term testicular germ cell tumor survivors","volume":"38","author":"Vehling","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/bjc.2014.552","article-title":"Increased stomach cancer risk following radiotherapy for testicular cancer","volume":"112","author":"Hauptmann","year":"2015","journal-title":"Br J Cancer"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1111\/j.1743-6109.2009.01299.x","article-title":"Hypogonadism, decreased sexual desire, and long-term depression in middle-aged men","volume":"6","author":"Hintikka","year":"2009","journal-title":"J Sex Med"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2017.76.7467","article-title":"Premature physiologic aging as a paradigm for understanding increased risk of adverse health across the lifespan of survivors of childhood cancer","volume":"36","author":"Ness","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref1751","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1200\/JCO.2015.64.8451","article-title":"Pulmonary function in patients with germ cell cancer treated with bleomycin, etoposide, and cisplatin","volume":"34","author":"Lauritsen","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","article-title":"Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer","volume":"25","author":"van den Belt-Dusebout","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref1561","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1200\/JCO.2016.70.3108","article-title":"Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy","volume":"35","author":"Fung","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref2011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000463782","article-title":"Spermatogenesis and hormonal status after orchiectomy for cancer and before supplementary treatment","volume":"10","author":"Foss\u00e5","year":"1984","journal-title":"Eur Urol"},{"key":"ref2021","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bju.14455","article-title":"Fertility management in testicular cancer: the need to establish a standardized and evidence-based patient-centric pathway","volume":"123","author":"Moody","year":"2019","journal-title":"BJU Int"},{"key":"ref2251","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/s41416-018-0044-7","article-title":"Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors","volume":"118","author":"Adams","year":"2018","journal-title":"Br J Cancer"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urology.2008.08.501","article-title":"Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer","volume":"73","author":"Pettus","year":"2009","journal-title":"Urology"},{"key":"ref1851","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.eururo.2007.02.046","article-title":"Is the sexual function compromised in long-term testicular cancer survivors?","volume":"52","author":"Dahl","year":"2007","journal-title":"Eur Urol"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/annonc\/mdf058","article-title":"Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer","volume":"13","author":"Strumberg","year":"2002","journal-title":"Ann Oncol"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1158\/1078-0432.CCR-18-3179","article-title":"Clinical and genome-wide analysis of cisplatin-induced tinnitus implicates novel ototoxic mechanisms","volume":"25","author":"El Charif","year":"2019","journal-title":"Clin Cancer Res"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11682-016-9552-3","article-title":"Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment","volume":"11","author":"Amidi","year":"2017","journal-title":"Brain Imaging Behav"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-87-3-293","article-title":"Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer","volume":"87","author":"Einhorn","year":"1977","journal-title":"Ann Intern Med"},{"key":"ref2301","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejso.2013.09.019","article-title":"Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis","volume":"40","author":"Gandaglia","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"459","DOI":"10.6004\/jnccn.2018.7109","article-title":"Adverse health outcomes in relationship to hypogonadism after chemotherapy: a multicenter study of testicular cancer survivors","volume":"17","author":"Abu Zaid","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/02841860701518058","article-title":"Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer","volume":"47","author":"Schagen","year":"2008","journal-title":"Acta Oncol"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"33298","DOI":"10.1074\/jbc.272.52.33298","article-title":"Gene characterization, promoter analysis, and chromosomal localization of human bleomycin hydrolase","volume":"272","author":"Ferrando","year":"1997","journal-title":"J Biol Chem"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/annonc\/mdf048","article-title":"Long-term renal function after treatment for malignant germ-cell tumours","volume":"13","author":"Foss\u00e5","year":"2002","journal-title":"Ann Oncol"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1200\/JCO.1993.11.9.1703","article-title":"Secondary neoplasms following treatment of malignant germ cell tumors","volume":"11","author":"Bokemeyer","year":"1993","journal-title":"J Clin Oncol"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/bjc.2012.471","article-title":"Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer","volume":"107","author":"Bryd\u00f8y","year":"2012","journal-title":"Br J Cancer"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1200\/JCO.2014.60.3654","article-title":"Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"33","author":"Fung","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/andr.12354","article-title":"Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome","volume":"5","author":"Bogefors","year":"2017","journal-title":"Andrology"},{"key":"ref2241","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/annonc\/mdv328","article-title":"Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors","volume":"26","author":"Sprauten","year":"2015","journal-title":"Ann Oncol"},{"key":"ref1511","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jacc.2007.06.037","article-title":"Early breast cancer therapy and cardiovascular injury","volume":"50","author":"Jones","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref1931","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0302-2838(03)00263-X","article-title":"Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer","volume":"44","author":"Nord","year":"2003","journal-title":"Eur Urol"},{"key":"ref2191","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/0284186X.2011.602113","article-title":"Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment","volume":"51","author":"Skoogh","year":"2012","journal-title":"Acta Oncol"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue\u2014mechanisms, risk factors, and treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.1999.17.4.1146","article-title":"Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial","volume":"17","author":"Foss\u00e5","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref2161","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11682-016-9552-3","article-title":"Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment","volume":"11","author":"Amidi","year":"2017","journal-title":"Brain Imaging Behav"},{"key":"ref1741","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1200\/JCO.2008.18.5181","article-title":"Pulmonary function in long-term survivors of testicular cancer","volume":"27","author":"Haugnes","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1200\/JCO.2015.64.8451","article-title":"Pulmonary function in patients with germ cell cancer treated with bleomycin, etoposide, and cisplatin","volume":"34","author":"Lauritsen","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref2231","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpsychores.2008.01.002","article-title":"Chronic cancer-related fatigue in long-term survivors of testicular cancer","volume":"64","author":"Orre","year":"2008","journal-title":"J Psychosom Res"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-16-3224","article-title":"Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer","volume":"23","author":"Dolan","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref2261","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","article-title":"Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis","volume":"3","author":"Mustian","year":"2017","journal-title":"JAMA Oncol"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br J Cancer"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<866::AID-IJC34>3.0.CO;2-9","article-title":"Platinum organ toxicity and possible prevention in patients with testicular cancer","volume":"83","author":"Hartmann","year":"1999","journal-title":"Int J Cancer"},{"key":"ref2321","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/jnci\/djq216","article-title":"Testicular cancer survivorship: research strategies and recommendations","volume":"102","author":"Travis","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br J Cancer"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01213011-200506000-00005","article-title":"Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients","volume":"15","author":"Nuver","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cncr.25298","article-title":"Cognitive impairment in men with testicular cancer prior to adjuvant therapy","volume":"117","author":"Wefel","year":"2011","journal-title":"Cancer"},{"key":"ref1681","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/01926230490508821","article-title":"Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology","volume":"32","author":"Vickers","year":"2004","journal-title":"Toxicol Pathol"},{"key":"ref2311","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref2151","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx085","article-title":"Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy","volume":"109","author":"Amidi","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1200\/JCO.2003.04.173","article-title":"Cardiovascular disease as a long-term complication of treatment for testicular cancer","volume":"21","author":"Huddart","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref1881","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4149\/neo_2009_06_473","article-title":"Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer","volume":"56","author":"Ondrusova","year":"2009","journal-title":"Neoplasma"},{"key":"ref2091","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1200\/JCO.2005.05.061","article-title":"Study of anxiety disorder and depression in long-term survivors of testicular cancer","volume":"23","author":"Dahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/jnci\/djq216","article-title":"Testicular cancer survivorship: research strategies and recommendations","volume":"102","author":"Travis","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"ref1831","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1743-6109.2009.01298.x","article-title":"Sexual function in men treated for testicular cancer","volume":"6","author":"Eberhard","year":"2009","journal-title":"J Sex Med"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2016.02.013","article-title":"Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients","volume":"59","author":"van der Schoot","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref981","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx085","article-title":"Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy","volume":"109","author":"Amidi","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud\u2019s phenomenon","volume":"375","author":"Wigley","year":"2016","journal-title":"N Engl J Med"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"26.e9","DOI":"10.1016\/j.urolonc.2012.09.003","article-title":"Long-term mortality in patients with germ cell tumors: effect of primary cancer site on cause of death","volume":"32","author":"Alanee","year":"2014","journal-title":"Urol Oncol"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4149\/neo_2009_06_473","article-title":"Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer","volume":"56","author":"Ondrusova","year":"2009","journal-title":"Neoplasma"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/jnci\/92.14.1165","article-title":"Treatment-associated leukemia following testicular cancer","volume":"92","author":"Travis","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/jnci\/92.14.1165","article-title":"Treatment-associated leukemia following testicular cancer","volume":"92","author":"Travis","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/eje.1.02088","article-title":"Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology","volume":"154","author":"Rochira","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1200\/JCO.2017.77.4174","article-title":"Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era","volume":"36","author":"Groot","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref1801","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/andr.12354","article-title":"Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome","volume":"5","author":"Bogefors","year":"2017","journal-title":"Andrology"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jacc.2007.06.037","article-title":"Early breast cancer therapy and cardiovascular injury","volume":"50","author":"Jones","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"e12390","DOI":"10.1097\/MD.0000000000012390","article-title":"Recent global trends in testicular cancer incidence and mortality","volume":"97","author":"Park","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref1131","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejso.2013.09.019","article-title":"Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis","volume":"40","author":"Gandaglia","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/bjc.2014.552","article-title":"Increased stomach cancer risk following radiotherapy for testicular cancer","volume":"112","author":"Hauptmann","year":"2015","journal-title":"Br J Cancer"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576 testicular cancer patients: focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref2131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11764-015-0468-5","article-title":"The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study","volume":"10","author":"Smith","year":"2016","journal-title":"J Cancer Surviv"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1200\/JCO.2012.41.8681","article-title":"Second malignant neoplasms: assessment and strategies for risk reduction","volume":"30","author":"Wood","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/02841860601166958","article-title":"Gonadal dysfunction and fertility problems in cancer survivors","volume":"46","author":"Bryd\u00f8y","year":"2007","journal-title":"Acta Oncol"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.urolonc.2008.10.026","article-title":"Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer","volume":"28","author":"Subramanian","year":"2010","journal-title":"Urol Oncol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/02841860701518058","article-title":"Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer","volume":"47","author":"Schagen","year":"2008","journal-title":"Acta Oncol"},{"key":"ref1641","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.clon.2019.04.008","article-title":"Neurotoxicity among survivors of testicular cancer: a population-based study","volume":"31","author":"Raphael","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1158\/1078-0432.CCR-16-2809","article-title":"Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity","volume":"23","author":"Wheeler","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref2111","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/pon.4596","article-title":"A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors","volume":"27","author":"Smith","year":"2018","journal-title":"Psychooncology"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"487.e13","DOI":"10.1016\/j.urolonc.2016.06.012","article-title":"Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors","volume":"34","author":"Hjelle","year":"2016","journal-title":"Urol Oncol"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.2005.05.4528","article-title":"Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors","volume":"25","author":"Motzer","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6904-8-7","article-title":"Long-term platinum retention after treatment with cisplatin and oxaliplatin","volume":"8","author":"Brouwers","year":"2008","journal-title":"BMC Clin Pharmacol"},{"key":"ref2121","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.urology.2006.12.022","article-title":"Health behaviors and depressive symptoms in testicular cancer survivors","volume":"69","author":"Shinn","year":"2007","journal-title":"Urology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"8671832","DOI":"10.1155\/2018\/8671832","article-title":"Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors","volume":"2018","author":"Fung","year":"2018","journal-title":"Adv Urol"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1479-5876-5-70","article-title":"Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study","volume":"5","author":"Oldenburg","year":"2007","journal-title":"J Transl Med"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"e761","DOI":"10.1016\/j.clgc.2018.01.011","article-title":"Predicting cardiovascular disease among testicular cancer survivors after modern cisplatin-based chemotherapy: application of the Framingham Risk Score","volume":"16","author":"Feldman","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"8671832","DOI":"10.1155\/2018\/8671832","article-title":"Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors","volume":"2018","author":"Fung","year":"2018","journal-title":"Adv Urol"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/jnci\/89.19.1429","article-title":"Risk of second malignant neoplasms among long-term survivors of testicular cancer","volume":"89","author":"Travis","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/annonc\/mdf058","article-title":"Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer","volume":"13","author":"Strumberg","year":"2002","journal-title":"Ann Oncol"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/1097-0142(20010401)91:7<1297::AID-CNCR1132>3.0.CO;2-Z","article-title":"The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors","volume":"91","author":"Gerl","year":"2001","journal-title":"Cancer"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1200\/JCO.2005.05.061","article-title":"Study of anxiety disorder and depression in long-term survivors of testicular cancer","volume":"23","author":"Dahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.2005.05.4528","article-title":"Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors","volume":"25","author":"Motzer","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2016.02.013","article-title":"Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients","volume":"59","author":"van der Schoot","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref1371","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1200\/JCO.2017.77.4174","article-title":"Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era","volume":"36","author":"Groot","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref1901","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2013.51.2715","article-title":"Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors","volume":"32","author":"Sprauten","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1200\/JCO.2012.41.8681","article-title":"Second malignant neoplasms: assessment and strategies for risk reduction","volume":"30","author":"Wood","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1470-2045(07)70246-2","article-title":"Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data","volume":"8","author":"Verdecchia","year":"2007","journal-title":"Lancet Oncol"},{"key":"ref1871","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/s41416-018-0044-7","article-title":"Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors","volume":"118","author":"Adams","year":"2018","journal-title":"Br J Cancer"},{"key":"ref1451","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"537","DOI":"10.6004\/jnccn.2012.0051","article-title":"Late cardiovascular toxicity following chemotherapy for germ cell tumors","volume":"10","author":"Feldman","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","article-title":"Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)","volume":"23","author":"Jones","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jamaoncol.2016.3651","article-title":"Second malignant neoplasms and cause of death in patients with germ cell cancer: a Danish nationwide cohort study","volume":"2","author":"Kier","year":"2016","journal-title":"JAMA Oncol"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/djk111","article-title":"Noncancer causes of death in survivors of testicular cancer","volume":"99","author":"Foss\u00e5","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/pon.3453","article-title":"A prospective study of cognitive function in men with non-seminomatous germ cell tumors","volume":"23","author":"Wefel","year":"2014","journal-title":"Psychooncology"},{"key":"ref1791","doi-asserted-by":"crossref","first-page":"459","DOI":"10.6004\/jnccn.2018.7109","article-title":"Adverse health outcomes in relationship to hypogonadism after chemotherapy: a multicenter study of testicular cancer survivors","volume":"17","author":"Abu Zaid","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","article-title":"Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up","volume":"30","author":"Haugnes","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/jnci\/dji339","article-title":"Paternity following treatment for testicular cancer","volume":"97","author":"Bryd\u00f8y","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref2331","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2017.76.7467","article-title":"Premature physiologic aging as a paradigm for understanding increased risk of adverse health across the lifespan of survivors of childhood cancer","volume":"36","author":"Ness","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref2141","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12032-014-0043-3","article-title":"Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors","volume":"31","author":"Alacacioglu","year":"2014","journal-title":"Med Oncol"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0959-8049(96)00458-3","article-title":"Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients","volume":"33","author":"Wander\u00e5s","year":"1997","journal-title":"Eur J Cancer"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bju.14455","article-title":"Fertility management in testicular cancer: the need to establish a standardized and evidence-based patient-centric pathway","volume":"123","author":"Moody","year":"2019","journal-title":"BJU Int"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.urology.2006.12.022","article-title":"Health behaviors and depressive symptoms in testicular cancer survivors","volume":"69","author":"Shinn","year":"2007","journal-title":"Urology"},{"key":"ref2101","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.genhosppsych.2015.09.001","article-title":"Anxiety and depression in long-term testicular germ cell tumor survivors","volume":"38","author":"Vehling","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud\u2019s phenomenon","volume":"375","author":"Wigley","year":"2016","journal-title":"N Engl J Med"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"e761","DOI":"10.1016\/j.clgc.2018.01.011","article-title":"Predicting cardiovascular disease among testicular cancer survivors after modern cisplatin-based chemotherapy: application of the Framingham Risk Score","volume":"16","author":"Feldman","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djp413","article-title":"Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors","volume":"101","author":"Bryd\u00f8y","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref2051","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/humrep\/del167","article-title":"Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients","volume":"21","author":"Gandini","year":"2006","journal-title":"Hum Reprod"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/annonc\/mdv369","article-title":"Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors","volume":"26","author":"Boer","year":"2015","journal-title":"Ann Oncol"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/pon.3804","article-title":"Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients","volume":"24","author":"Amidi","year":"2015","journal-title":"Psychooncology"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","article-title":"Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Loren","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.clon.2019.04.008","article-title":"Neurotoxicity among survivors of testicular cancer: a population-based study","volume":"31","author":"Raphael","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","article-title":"Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer","volume":"25","author":"van den Belt-Dusebout","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/annonc\/mdu506","article-title":"Renal impairment and late toxicity in germ-cell cancer survivors","volume":"26","author":"Lauritsen","year":"2015","journal-title":"Ann Oncol"},{"key":"ref1401","first-page":"2155","article-title":"Second cancers","volume-title":"DeVita, Hellman, and Rosenberg\u2019s Cancer: Principles & Practice of Oncology","author":"Fung","year":"2017"},{"key":"ref1501","doi-asserted-by":"crossref","first-page":"537","DOI":"10.6004\/jnccn.2012.0051","article-title":"Late cardiovascular toxicity following chemotherapy for germ cell tumors","volume":"10","author":"Feldman","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"ref1581","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2015.10.003","article-title":"Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links","volume":"35","author":"Sawant","year":"2015","journal-title":"DNA Repair (Amst)"},{"key":"ref2221","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue\u2014mechanisms, risk factors, and treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"ref1541","doi-asserted-by":"crossref","first-page":"26.e9","DOI":"10.1016\/j.urolonc.2012.09.003","article-title":"Long-term mortality in patients with germ cell tumors: effect of primary cancer site on cause of death","volume":"32","author":"Alanee","year":"2014","journal-title":"Urol Oncol"},{"key":"ref1921","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-07-0684","article-title":"Risk factors for post-treatment hypogonadism in testicular cancer patients","volume":"158","author":"Eberhard","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"ref2001","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2010.03.041","article-title":"Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy","volume":"58","author":"Bryd\u00f8y","year":"2010","journal-title":"Eur Urol"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2013.51.2715","article-title":"Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors","volume":"32","author":"Sprauten","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref1951","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6602677","article-title":"Fertility, gonadal and sexual function in survivors of testicular cancer","volume":"93","author":"Huddart","year":"2005","journal-title":"Br J Cancer"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/0284186X.2011.602113","article-title":"Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment","volume":"51","author":"Skoogh","year":"2012","journal-title":"Acta Oncol"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2017.77.0735","article-title":"Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study","volume":"36","author":"Kerns","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/humrep\/del167","article-title":"Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients","volume":"21","author":"Gandini","year":"2006","journal-title":"Hum Reprod"},{"key":"ref1991","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0015-0282(03)00335-2","article-title":"Fertility in men with testicular germ cell tumors","volume":"79","author":"Spermon","year":"2003","journal-title":"Fertil Steril"},{"key":"ref1531","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/djk111","article-title":"Noncancer causes of death in survivors of testicular cancer","volume":"99","author":"Foss\u00e5","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/cncr.24981","article-title":"Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer","volume":"116","author":"Glendenning","year":"2010","journal-title":"Cancer"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/annonc\/mdv369","article-title":"Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors","volume":"26","author":"Boer","year":"2015","journal-title":"Ann Oncol"},{"key":"ref1621","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1158\/1078-0432.CCR-18-3179","article-title":"Clinical and genome-wide analysis of cisplatin-induced tinnitus implicates novel ototoxic mechanisms","volume":"25","author":"El Charif","year":"2019","journal-title":"Clin Cancer Res"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6904-8-7","article-title":"Long-term platinum retention after treatment with cisplatin and oxaliplatin","volume":"8","author":"Brouwers","year":"2008","journal-title":"BMC Clin Pharmacol"},{"key":"ref2031","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ucl.2015.05.003","article-title":"Infertility with testicular cancer","volume":"42","author":"Ostrowski","year":"2015","journal-title":"Urol Clin North Am"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.juro.2010.06.146","article-title":"Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection","volume":"184","author":"Beck","year":"2010","journal-title":"J Urol"},{"key":"ref2181","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cncr.25298","article-title":"Cognitive impairment in men with testicular cancer prior to adjuvant therapy","volume":"117","author":"Wefel","year":"2011","journal-title":"Cancer"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"33298","DOI":"10.1074\/jbc.272.52.33298","article-title":"Gene characterization, promoter analysis, and chromosomal localization of human bleomycin hydrolase","volume":"272","author":"Ferrando","year":"1997","journal-title":"J Biol Chem"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0015-0282(03)00335-2","article-title":"Fertility in men with testicular germ cell tumors","volume":"79","author":"Spermon","year":"2003","journal-title":"Fertil Steril"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/pon.4596","article-title":"A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors","volume":"27","author":"Smith","year":"2018","journal-title":"Psychooncology"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2010.03.041","article-title":"Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy","volume":"58","author":"Bryd\u00f8y","year":"2010","journal-title":"Eur Urol"},{"key":"ref1471","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1200\/JCO.2003.04.173","article-title":"Cardiovascular disease as a long-term complication of treatment for testicular cancer","volume":"21","author":"Huddart","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref231","first-page":"2155","article-title":"Second cancers","volume-title":"DeVita, Hellman, and Rosenberg\u2019s Cancer: Principles & Practice of Oncology","author":"Fung","year":"2017"},{"key":"ref2201","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/pon.3453","article-title":"A prospective study of cognitive function in men with non-seminomatous germ cell tumors","volume":"23","author":"Wefel","year":"2014","journal-title":"Psychooncology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<866::AID-IJC34>3.0.CO;2-9","article-title":"Platinum organ toxicity and possible prevention in patients with testicular cancer","volume":"83","author":"Hartmann","year":"1999","journal-title":"Int J Cancer"},{"key":"ref2061","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.juro.2010.06.146","article-title":"Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection","volume":"184","author":"Beck","year":"2010","journal-title":"J Urol"},{"key":"ref1971","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2017.11.039","article-title":"Is testicular dysgenesis syndrome a genetic, endocrine, or environmental disease, or an unexplained reproductive disorder?","volume":"194","author":"Xing","year":"2018","journal-title":"Life Sci"},{"key":"ref1551","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1200\/JCO.2014.60.3654","article-title":"Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"33","author":"Fung","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.1999.17.4.1146","article-title":"Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial","volume":"17","author":"Foss\u00e5","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11136-005-5370-6","article-title":"Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors","volume":"15","author":"Oldenburg","year":"2006","journal-title":"Qual Life Res"},{"key":"ref1691","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/annonc\/mdf048","article-title":"Long-term renal function after treatment for malignant germ-cell tumours","volume":"13","author":"Foss\u00e5","year":"2002","journal-title":"Ann Oncol"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","article-title":"Evaluation of long-term toxicity after chemotherapy for testicular cancer","volume":"14","author":"Bokemeyer","year":"1996","journal-title":"J Clin Oncol"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6602677","article-title":"Fertility, gonadal and sexual function in survivors of testicular cancer","volume":"93","author":"Huddart","year":"2005","journal-title":"Br J Cancer"},{"key":"ref1461","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/annonc\/mdu506","article-title":"Renal impairment and late toxicity in germ-cell cancer survivors","volume":"26","author":"Lauritsen","year":"2015","journal-title":"Ann Oncol"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ucl.2015.05.003","article-title":"Infertility with testicular cancer","volume":"42","author":"Ostrowski","year":"2015","journal-title":"Urol Clin North Am"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"78253","DOI":"10.18632\/oncotarget.20872","article-title":"Salvage therapy for relapsed testicular cancer","volume":"8","author":"Adra","year":"2017","journal-title":"Oncotarget"},{"key":"ref1141","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000463782","article-title":"Spermatogenesis and hormonal status after orchiectomy for cancer and before supplementary treatment","volume":"10","author":"Foss\u00e5","year":"1984","journal-title":"Eur Urol"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/annonc\/mdv328","article-title":"Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors","volume":"26","author":"Sprauten","year":"2015","journal-title":"Ann Oncol"},{"key":"ref1671","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2015.10.003","article-title":"Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links","volume":"35","author":"Sawant","year":"2015","journal-title":"DNA Repair (Amst)"},{"key":"ref2071","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.urolonc.2008.10.026","article-title":"Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer","volume":"28","author":"Subramanian","year":"2010","journal-title":"Urol Oncol"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<860::AID-IJC32>3.0.CO;2-L","article-title":"Therapy-related malignancies following treatment of germ cell cancer","volume":"83","author":"Kollmannsberger","year":"1999","journal-title":"Int J Cancer"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/jnci\/89.19.1429","article-title":"Risk of second malignant neoplasms among long-term survivors of testicular cancer","volume":"89","author":"Travis","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"ref1101","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00003446-198205000-00006","article-title":"The hearing handicap inventory for the elderly: a new tool","volume":"3","author":"Ventry","year":"1982","journal-title":"Ear Hear"},{"key":"ref1361","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576 testicular cancer patients: focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1634\/theoncologist.2017-0457","article-title":"Long-term cognitive functioning in testicular germ-cell tumor survivors","volume":"23","author":"Chovanec","year":"2018","journal-title":"Oncologist"},{"key":"ref1441","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0959-8049(96)00458-3","article-title":"Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients","volume":"33","author":"Wander\u00e5s","year":"1997","journal-title":"Eur J Cancer"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1200\/JCO.1993.11.9.1703","article-title":"Secondary neoplasms following treatment of malignant germ cell tumors","volume":"11","author":"Bokemeyer","year":"1993","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1470-2045(07)70246-2","article-title":"Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data","volume":"8","author":"Verdecchia","year":"2007","journal-title":"Lancet Oncol"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2017.11.039","article-title":"Is testicular dysgenesis syndrome a genetic, endocrine, or environmental disease, or an unexplained reproductive disorder?","volume":"194","author":"Xing","year":"2018","journal-title":"Life Sci"},{"key":"ref2271","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00003446-198205000-00006","article-title":"The hearing handicap inventory for the elderly: a new tool","volume":"3","author":"Ventry","year":"1982","journal-title":"Ear Hear"},{"key":"ref1911","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/andr.12177","article-title":"Testosterone deficiency in testicular cancer survivors\u2014a systematic review and meta-analysis","volume":"4","author":"Bandak","year":"2016","journal-title":"Andrology"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11764-015-0468-5","article-title":"The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study","volume":"10","author":"Smith","year":"2016","journal-title":"J Cancer Surviv"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.eururo.2007.02.046","article-title":"Is the sexual function compromised in long-term testicular cancer survivors?","volume":"52","author":"Dahl","year":"2007","journal-title":"Eur Urol"},{"key":"ref1891","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/eje.1.02088","article-title":"Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology","volume":"154","author":"Rochira","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"ref2211","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1634\/theoncologist.2017-0457","article-title":"Long-term cognitive functioning in testicular germ-cell tumor survivors","volume":"23","author":"Chovanec","year":"2018","journal-title":"Oncologist"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMra1407550","article-title":"Testicular cancer\u2014discoveries and updates","volume":"371","author":"Hanna","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/17\/12\/article-p1557.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T06:10:13Z","timestamp":1722147013000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/17\/12\/article-p1557.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":230,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2019.7369","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}